NeuCyte

About:

NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.

Website: https://www.neucyte.com/

Twitter/X: neucyte

Top Investors: Leaguer Venture Capital, Cowin Venture, Wisemont Capital

Description:

NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.

Total Funding Amount:

$6.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

2015-01-01

Contact Email:

Enquiries(AT)neucyte.com

Founders:

Jonathan Davila

Number of Employees:

11-50

Last Funding Date:

2018-05-08

IPO Status:

Private

Industries: